NDC 24275-0185-01 - Fludeoxyglucose F18
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24275-0185
- Requested NDC
- 24275-0185-01
- Package NDCs from labels
- 24275-0185-1, 24275-0185-01
- Manufacturer
- UCSF Radiopharmaceutical Facility
- Effective date
- 2025-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fludeoxyglucose F18 - UCSF Radiopharmaceutical Facility | UCSF Radiopharmaceutical Facility | 2025-11-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24275-0185-1 | Fludeoxyglucose F18 | 17 mL in 1 VIAL, GLASS | INJECTION | 17 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24275-0185 | FLUDEOXYGLUCOSE F18 INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 17 | Current NDC, Legacy NDC, 1 package rows | 20241013_763958a2-6952-4c0d-8a4a-9c04acb62229.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FLUDEOXYGLUCOSE F-18 | ACTIVE INGREDIENT | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 9 | |
| FLUDEOXYGLUCOSE F-18 | ACTIVE MOIETY | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | Massachusetts General Hospital | 232fbb91-402e-44d8-a0cf-6813980b8ead | 2021-11-25 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| FLUDEOXYGLUCOSE F-18 | FLUDEOXYGLUCOSE F-18 | BRIGHAM AND WOMEN`S HOSPITAL, INC., THE | 6b7b71c9-f10c-4ace-8166-ea242d8e628d | 2021-11-03 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F 18 | Washington University School of Medicine | ae48ac7d-1c50-4b32-a3e6-c2e5de5b63ed | 2021-10-29 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | The Methodist Hospital Research Institute | 195d1b07-5669-247f-e054-00144ff8d46c | 2021-08-13 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F-18 | FLUDEOXYGLUCOSE F-18 | Cardinal Health 414, LLC | 08044d8f-036c-4809-997f-dd5180feebe6 | 2020-12-04 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH | dfd91498-4bfc-4d45-a9a3-cee6153ae573 | 2019-07-11 | Warnings, Adverse reactions | 0Z5B2CJX4D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.